Drägerwerk AG & Co. KGaA (ETR:DRW3)

Market Cap	1.56B +39.6%
Revenue (ttm)	3.57B +6.4%
Net Income	171.28M +71.5%
EPS	9.13 +71.5%
Shares Out	18.76M
PE Ratio	10.48
Forward PE	11.05
Dividend	2.27 (2.37%)
Ex-Dividend Date	May 11, 2026

Volume	46,027
Open	96.50
Previous Close	96.30
Day's Range	94.30 - 97.90
52-Week Range	66.00 - 125.40
Beta	0.60
Analysts	Buy
Price Target	110.25 (+15.2%)
Earnings Date	Oct 29, 2026

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1889
• Employees: 16,009
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DRW3

Financial Performance

In 2025, Drägerwerk AG & Co. KGaA's revenue was 3.48 billion, an increase of 3.29% compared to the previous year's 3.37 billion. Earnings were 139.50 million, an increase of 12.13%.

Analyst Summary

According to 5 analysts, the average rating for DRW3 stock is "Buy." The 12-month stock price target is €110.25, which is an increase of 15.20% from the latest price.

Price Target

€110.25

(15.20% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 16, 2026

Data Sources Report a data error